Albertsons Companies Inc (ACI)
UnterbewertetFundamental
54
Kurs
$11.61
Marktkapitalisierung
$5.70B
Teil 1 · Was das Unternehmen wert ist
Übersicht
Albertsons Companies is one of the largest food and drug retailers in the United States. At the end of fiscal 2025 (the 53 weeks ended 28 February 2026) it operated 2,244 supermarkets in 35 states and the District of Columbia under 22 local banners, including Albertsons, Safeway, Vons, Jewel-Osco and Shaw's. Inside those stores it runs 1,713 pharmacies, 1,240 coffee shops and 405 fuel centres, supported by 22 distribution centres and 19 manufacturing plants and about 280,000 employees. Customers buy in the store or order online for delivery (available from more than 2,200 locations) or Drive Up & Go curbside pickup (more than 2,100 stores), partly through Instacart, DoorDash and Uber. The company reports its operating divisions as a single reportable segment.
Wie das Geld verdient wird
Albertsons makes money by buying goods and reselling them at a modest mark-up: almost all revenue is the till receipt of a grocery shopper, recognised at the point of sale. Fiscal 2025 net sales and other revenue were $83,172.5 million, of which $82,359.4 million came from retail sales and $813.1 million from other revenue such as wholesale, rental income and its retail media business. Because the company does not split into business segments, the only revenue breakdown it publishes is by product type: packaged groceries and general merchandise, fresh food, prescriptions filled in the in-store pharmacies, fuel, and a small residual. Own Brands — more than 14,000 private-label items under names like Signature SELECT and O Organics — generated $16.9 billion of those retail sales and carry a higher margin than national brands. Profitability rests on very thin margins across an enormous volume: in fiscal 2025 merchandise costs absorbed $58,789.1 million and employee costs $12,218.8 million, leaving income before income taxes of $267.8 million.
Umsatz nach Segment
Packaged and shelf-stable groceries plus general merchandise, health and beauty products sold to households doing their regular shop. It is the largest product category, $40,624.8 million in fiscal 2025, and its share has drifted slowly down as pharmacy has grown.
Perishable food — produce, meat, deli, bakery, dairy — sold in store and through the digital channels. Worth $26,024.2 million in fiscal 2025, it is the part of the assortment retailers use to differentiate themselves on quality rather than price.
Prescriptions, vaccinations and related services dispensed in 1,713 in-store pharmacies, largely paid by insurers and pharmacy benefit managers rather than by the patient directly. At $11,414.9 million it is the fastest-growing category, up from 10.4% of sales two years earlier.
Petrol sold at 405 fuel centres attached to the stores, usually tied to the loyalty programme to pull shoppers into the supermarket. Revenue of $3,803.0 million in fiscal 2025 moves with the pump price and has been shrinking as a share of the total.
A small residual of wholesale sales to third parties, rental income and other revenue such as the company's retail media business, worth $1,305.6 million in fiscal 2025.
Wettbewerbsvorteil
Skaleneffekte · SchmalWhat Albertsons has is local density rather than a true national advantage. With 2,244 stores, 22 distribution centres and 19 plants it can fill shelves cheaply in the regions where its banners are strong, and its 14,000-item Own Brands range ($16.9 billion of sales) earns more per unit than national brands. But the company itself describes the industry as intensely competitive and its margins as low: in fiscal 2025, $83.2 billion of sales produced $267.8 million of pre-tax income. Groceries are not a product customers are locked into — the next supermarket is usually a few minutes away — and Albertsons is smaller than Walmart and Costco, so the advantage does not extend to setting prices.
Was die Nachfrage antreibt
DefensivPeople eat and fill prescriptions in every phase of the cycle, so volumes are remarkably stable: roughly 80% of sales are food and another 13.7% are pharmacy, both non-discretionary. What moves with the economy is not how much is sold but the mix and the margin — in hard times shoppers trade down to private label (helpful, since Own Brands are more profitable), buy fewer prepared and premium items, and cook at home more, which can actually raise grocery volumes. Food price inflation and deflation swing reported sales far more than recessions do, and the fuel category, 4.6% of revenue, simply follows the pump price. The offsetting pressure is competitive rather than cyclical: the risk is a rival taking the basket, not the basket disappearing.
Wichtigste Risiken
- Competition in the industry is intense — The company states it competes with regional and national chains, supercentres, discounters and online retailers, that competitors have aggressively added locations and moved to multi-channel selling, and that profit margins in food retail are low — so it must keep investing in price, stores and digital capability simply to hold its share.
- A large majority of employees are unionised — About 190,000 of roughly 280,000 associates work under collective bargaining agreements. Contracts covering 126,000 employees were renegotiated during fiscal 2025 and agreements covering a further 22,000 expire in fiscal 2026. The company warns that failing to agree acceptable terms could lead to strikes and significantly disrupt operations, and that increased wage and benefit costs flow straight through its thin margins.
- Multiemployer pension plans — Albertsons contributed to 28 multiemployer pension plans in fiscal 2025. Poor investment performance in those plans can raise required contributions and pension expense, and withdrawing from a plan — for example by exiting a market — can trigger a substantial withdrawal liability the company does not control.
- Changes in the healthcare industry and pharmacy reimbursement — Consolidation among insurers and pharmacy benefit managers has created counterparties with greater bargaining power over reimbursement rates, and the Medicare Drug Price Negotiation Program taking effect in 2026 lets the federal government negotiate prices on selected drugs. The company says these developments could reduce its pharmacy revenue and profitability — a risk that matters more now that pharmacy is 13.7% of sales.
- General economic conditions, inflation and deflation — The company describes a double bind: food deflation can reduce sales growth and earnings, while food inflation can compress gross margin rates and push shoppers to spend less or trade down. It adds that it is difficult for food retailers to deliver positive identical-store sales growth consistently.
- Dependence on energy and fuel — Running stores, distribution centres, manufacturing plants and a delivery fleet requires significant energy and fuel, and the company lists volatility or unavailability of that supply as a risk to its operations and costs.
- Failure to keep up with changing consumer preferences — Albertsons flags the risk of not identifying or responding quickly enough to shifts in what customers want and how they want to buy it — the assortment they expect, and the growing share of orders placed digitally for delivery or curbside pickup.
Kundenkonzentration
There is no customer concentration to report: Albertsons sells to millions of individual shoppers through 2,244 stores and its digital channels, and the 10-K discloses no major customer. The concentration that does exist is on the other side of the till — the company states that it is not dependent on any individual supplier and that only one third-party supplier represented more than 5% of its sales in fiscal 2025, which in food and drug retail is typically the wholesale drug distributor supplying the pharmacies. A separate, indirect concentration sits in pharmacy, where a handful of insurers and pharmacy benefit managers, not the patients, set the reimbursement Albertsons receives.
Die Argumente dafür
Buyers argue that this is a defensive, cash-generating business bought at the price of a struggling one. Sales grew 3.5% to $83.2 billion in fiscal 2025 without the company opening much, driven by pharmacy — up from 10.4% to 13.7% of sales in two years — and by digital orders, which grew far faster than the store base. They point to Own Brands at $16.9 billion, a higher-margin range the company controls end to end through its own 19 plants, and to a retail media business inside the 'Other' line that monetises shopper data at margins a supermarket cannot earn on groceries. They also note that fiscal 2025 pre-tax income of $267.8 million was struck after $802.9 million of legal and regulatory accruals and $84.1 million of merger-related costs — items they read as one-off — against retail segment EBITDA of $4,401.0 million, so the underlying cash generation is far larger than the reported bottom line suggests.
Die Argumente dagegen
Sellers fear a business with almost no room for error. Fiscal 2025 turned $83.2 billion of sales into $267.8 million of pre-tax income: merchandise cost $58,789.1 million and employees $12,218.8 million, so a small move in either wipes out the result — and the company itself says food inflation squeezes gross margin while deflation squeezes sales. They point to 190,000 unionised associates, contracts covering 22,000 more expiring in fiscal 2026, and 28 multiemployer pension plans whose contributions and withdrawal liabilities Albertsons does not control. The growth engine is the part sellers trust least: pharmacy, now 13.7% of sales, is paid by consolidated insurers and benefit managers with rising bargaining power, and from 2026 by a federal drug price negotiation programme the company warns could hurt its revenue and profitability. Behind all of it sits an intensely competitive industry where Walmart, Costco and online grocers are larger, the customer is a few minutes from another store, and the $802.9 million of legal and regulatory accruals booked in fiscal 2025 suggests such charges are not always as exceptional as they look.
Generated on 17. September 2026 with claude-haiku-4-5 — shared with all users
Direct competitors
Who this company fights with for the same customers
Generated on 17. September 2026 with claude-haiku-4-5 — shared with all users
The other large traditional US supermarket operator, running multi-banner grocery and in-store pharmacy formats that overlap with Albertsons' banners in most of the same metropolitan markets.
The largest seller of groceries in the United States, whose supercenters pull the same weekly food shop away from Albertsons stores on price.
A membership club whose food, fresh and pharmacy business takes bulk grocery spending from the same households Albertsons serves in the West.
Its US banners — Stop & Shop, Giant, Food Lion and Hannaford — are conventional supermarkets competing store-for-store with Albertsons' ACME, Shaw's and Star Market on the East Coast.
A conventional full-service supermarket chain competing for the same middle-market grocery customer in the Southeast, where Albertsons has little presence but Publix sets the service standard.
The dominant privately held supermarket chain in Texas, competing head-on with Albertsons' Tom Thumb, Randalls, United Supermarkets and Market Street banners.
Bilanz & Liquidität
Umsatz
$83.23B
Letzte 12 Monate (bis 20.6.2026)
Nettogewinn
$66M
Letzte 12 Monate (bis 20.6.2026)
Freier Cashflow
$527M
Gesamtes Eigenkapital
$1.84B
Gesamtverbindlichkeiten
$24.93B
Current Ratio
0.84
Zinsdeckungsgrad
1.60
Schulden/EBITDA
5.94
Gewinn je Aktie
Umsatz & Nettogewinn
Freier Cashflow
Ertragsaufschlüsselung
Historische Aufstellung
Margen im Zeitverlauf
Verschuldung im Zeitverlauf
Wie schwer die Schulden wiegen
Wachstumsraster
Wachstum — Umsatz
Innerer-Wert-Schätzung
Innerer Wert
$27.12
Aktueller Kurs
$11.61
Sicherheitsmarge
+57.2%
Innerer-Wert-Spanne
$17.63 - $36.62
Streubreite zwischen den verwendeten Bewertungsmethoden, kein statistisch kalibriertes Konfidenzintervall.
Bewertungsmethoden
Bewertungskennzahlen
P/E-Verhältnis
72.56
ROE
11.8%
P/B-Verhältnis
3.49
P/FCF
9.99
Bruttomarge
27.0%
ROIC
2.3%
Rentabilitäts-Radar
Wertschöpfung (Wettbewerbsvorteil)
ROIC
2.3%
WACC
3.8%
ROIC − WACC
-1.5 pp
Der ROIC liegt unter den Kapitalkosten: Das Unternehmen vernichtet für jeden investierten Dollar Wert.
Fundamentalanalyse-Kriterien
Bestanden (11)
- EPS shows upward trend
- EPS CAGR 22.28%
- P/FCF 9.99
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- DCF valuation (Undervalued)
- Earnings Quality (OCF/NI) 35.63
- Share Dilution -7.0%
- Piotroski F-Score 5/9
Nicht bestanden (15)
- Price CAGR -6.06%
- ROIC 2.3%
- Gross Margin 27.0%
- P/B Ratio 3.49
- Debt/Equity ratio
- Operating Margin 0.7%
- CapEx intensity
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- ROE 2.9%
- Revenue Growth 5Y 3.6%
- Analyst Consensus 42% Buy
- Earnings Surprise avg 0.4%
- Net Margin Trend 0.1% vs 1.2%
Nicht verfügbar (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Gemischte Signale: Einige Bereiche bedürfen Aufmerksamkeit
Gewinnqualität
Hohe Qualität: Gewinne durch Cashflow gedeckt
Aktienverwässerung
Aktienrückkäufe. Aktionärsfreundlich
Institutionelle Beteiligungen
Unternehmensführung
Führungsteam
| Name | Position | Alter |
|---|---|---|
| Ms. Susan D. Morris | CEO & Director | 56 |
| Ms. Sharon L. McCollam CPA | President & CFO | 62 |
| Mr. Anuj Dhanda Ph.D. | Executive VP and Chief Technology & Transformation Officer | 62 |
| Ms. Jennifer Saenz | Executive VP & Chief Commercial Officer | 47 |
| Mr. Thomas Michael Moriarty J.D. | Executive Vice President of M&A and Corporate Affairs | 61 |
| Mr. Robert B. Larson | Senior VP & Chief Accounting Officer | 54 |
| Mr. Cody Perdue | Senior Vice President of Treasury, Investor Relations and Risk Management | - |
| Mr. Justin Ewing | Executive Vice President of Corporate Development & Real Estate | 56 |
| Ms. Allison Pinkham | Executive VP & Chief Human Resources Officer | 50 |
| Mr. Wayne A. Denningham | Executive Vice President of California Region | 63 |
Prüfungsrisiko
6
Vorstandsrisiko
2
Vergütungsrisiko
3
Aktionärsrechterisiko
2
Teil 2 · Der Preis und der Einstiegszeitpunkt
Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.
Dokumente
- Dokument ansehen
Jahresbericht (10-K)
Ein jährlicher Überblick über das Geschäft, die Finanzergebnisse und die Risiken des Unternehmens.
Eingereicht am 2026-04-27
- Dokument ansehen
Quartalsbericht (10-Q)
Ein Update zur finanziellen Entwicklung der letzten drei Monate.
Eingereicht am 2026-07-28
- Dokument ansehen
Ad-hoc-Meldung (8-K)
Eine Mitteilung über ein wichtiges Ereignis, etwa einen Führungswechsel oder eine bedeutende Ankündigung.
Eingereicht am 2026-09-30
via SEC EDGAR
Ertragshistorie
via SEC EDGAR
Latest News
Recent headlines for ACI, sourced from Markets Gazette.
- 4/14/2026NEGATIVEAlbertsons cites slower GLP-1 growth, higher gas prices for a sales miss and downbeat outlook
Albertsons reported a sales miss, with revenue falling short of expectations due to slower growth in GLP-1 medications and higher gas prices impacting consumer spending. The grocery chain also announced a significant $774 million settlement to resolve opioid-related claims. These combined factors have led to a downbeat outlook for the company. For investors, the miss signals potential headwinds in consumer behavior and ongoing legal liabilities, which could weigh on future performance and profitability.
- 4/10/2026NEUTRALAlbertsons Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Albertsons is set to report its fourth-quarter earnings on April 14, with analysts projecting revenue of $20.47 billion. The company's stock, ACI, has seen mixed analyst ratings, with an accuracy range of 60-68% for recent predictions. While specific rating changes are not detailed in this update, the mixed sentiment suggests a cautious outlook from Wall Street. Investors will be closely watching the earnings report for any significant deviations from expectations, which could influence future analyst actions and stock performance.
- 2/20/2026NEGATIVEInside a $75 Million Albertsons Stock Sale as Shares Sink 8% in a Year
News of a $75 million Albertsons stock sale, occurring as the stock has fallen 8% in a year, suggests selling pressure or a lack of confidence from insiders or large investors. This event, coupled with the stock's decline, indicates negative sentiment.
via Markets Gazette